Smoking Compromises Cause-specific Survival in Patients with Operable Colorectal Cancer

Clinical Oncology

Volumn 18, Issue 6, 2006, Pages 436-440

  Munro, A J ^a   Bentley, A H M ^a   Ackland, C ^a   Boyle, P J ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

co morbidity; Colorectal cancer; smoking; socio economic deprivation; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33745399273     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.04.009     Document Type: Article

References (26)

1. Munro A.J., and Bentley A.H.M. Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer. Eur J Cancer Care 13 (2004) 254-262
2. Wrigley H., Roderick P., George S., Smith J., Mullee M., and Goddard J. Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Commun Health 57 (2003) 301-309
3. Munro A.J. Keynote comment: deprivation and survival in patients with cancer: we know so much, but do so little. Lancet Oncol 6 (2005) 912-913
4. Yancik R., Wesley M.N., Ries L.A., et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 82 (1998) 2123-2134
5. Pearce J., and Boyle P. Is the urban excess in lung cancer in Scotland explained by patterns of smoking?. Social Sci Med 60 (2005) 2833-2843
6. Carstairs V., and Morris R. Deprivation and health in Scotland (1991), Aberdeen University Press, Aberdeen
7. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
8. Shaw A, McMunn A, Field J. The Scottish Health Survey 1998: a survey carried out on behalf of the Scottish Executive Department of Health: Scottish Executive; 2000.
9. Browman G.P., Wong G., Hodson I., et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328 (1993) 159-163
10. Jadallah F., McCall J.L., and van Rij A.M. Recurrence and survival after potentially curative surgery for colorectal cancer. N Z Med J 112 (1999) 248-250
11. Cairns R.A., and Hill R.P. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 64 (2004) 2054-2061
12. Grau C., Horsman M.R., and Overgaard J. Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. Int J Radiat Oncol Biol Phys 22 (1992) 421-424
13. Maxwell P.H., Dachs G.U., Gleadle J.M., et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94 (1997) 8104-8109
14. Teicher B.A. Hypoxia and drug resistance. Cancer Metastasis Rev 13 (1994) 139-168
15. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., and Cho C.H. The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 311 (2004) 123-130
16. Ye Y.N., Wu W.K., Shin V.Y., and Cho C.H. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur J Pharmacol 519 (2005) 52-57
17. Faber M.S., Jetter A., and Fuhr U. Assessment of CYP1A2 activity in clinical practice: why, how, and when?. Basic Clin Pharmacol Toxicol 97 (2005) 125-134
18. Meliska C.J., Stunkard M.E., Gilbert D.G., Jensen R.A., and Martinko J.M. Immune function in cigarette smokers who quit smoking for 31 days. J Allergy Clin Immunol 95 (1995) 901-910
19. O'Byrne K.J., Dalgleish A.G., Browning M.J., Steward W.P., and Harris A.L. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 36 (2000) 151-169
20. Gross N.D., Boyle J.O., Morrow J.D., et al. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin Cancer Res 11 (2005) 6087-6093
21. Kuschner W.G., D'Alessandro A., Wong H., and Blanc P.D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9 (1996) 1989-1994
22. Rubin H. Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis. Oncogene 21 (2002) 7392-7411
23. Pulling L.C., Vuillemenot B.R., Hutt J.A., Devereux T.R., and Belinsky S.A. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 64 (2004) 3844-3848
24. Russo A.L., Thiagalingam A., Pan H., et al. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11 (2005) 2466-2470
25. Hoffmann H., Hogel J., and Speit G. The effect of smoking on DNA effects in the comet assay: a meta-analysis. Mutagenesis 20 (2005) 455-466
26. Wang L.E., Bondy M.L., de Andrade M., et al. Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res 154 (2000) 20-27